Knowledge and expectations of patients receiving aeroallergen immunotherapy

Annals of Allergy, Asthma and Immunology

Volumn 91, Issue 5, 2003, Pages 444-448

  Sade, Kobi ^a,b,c,d   Berkun, Yakkov ^b   Dole, Zevi ^c   Shalit, Meir ^b   Kivity, Shmuel ^a,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c Allergy Department   (Israel)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN;

ADULT; ALLERGIC RHINITIS; ALLERGY; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DRUG RESPONSE; EVALUATION; FEMALE; HEALTH CENTER; HEALTH EDUCATION; HUMAN; IMMUNOTHERAPY; INTERVIEW; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATIENT INFORMATION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SCIENCE; TREATMENT OUTCOME; UNIVERSITY;

EID: 0345256540     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61511-6     Document Type: Article

References (18)

1. Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 1998;81:478-518.
2. Blackwell B. Patient compliance. N Engl J Med. 1973;289: 249-252.
3. Eggleston PA. Clinical trials of allergen avoidance in established asthma. J Allergy Clin Immunol. 2001;108:685-687.
4. Gore RB, Custovic A. Is allergen avoidance effective? Clin Exp Allergy. 2002;32:662-666.
5. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases: a WHO position paper. J Allergy Clin Immunol. 1998;102:558-562.
6. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Practice parameters for allergen immunotherapy. J Allergy Clin Immunol. 1996;98: 1001-1011.
7. Greineder DK. Risk management in allergen immunotherapy. J Allergy Clin Immunol. 1996;98:S330-S334.
8. Malling HJ. Minimising the risks of allergen-specific injection immunotherapy. Drug Saf. 2000;23:323-332.
9. Tinkelman D, Smith F, Cole WQ, Silk HJ. Compliance with an allergen immunotherapy regime. Ann Allergy Asthma Immunol. 1995;74:241-246.
10. Cohn JR, Pizzi A. Determinants of patient compliance with allergen immunotherapy. J Allergy Clin Immunol. 1993;91: 734-737.
11. Lower T, Henry J, Mandik L, Janosky J, Friday GA Jr. Compliance with allergen immunotherapy. Ann Allergy. 1993;70: 480-482.
12. Rhodes BJ. Patient dropouts before completion of optimal dose, multiple allergen immunotherapy. Ann Allergy Asthma Immunol. 1999;82:281-286.
13. Hilton S, Sibbald B, Anderson HR, Freeling P. Controlled evaluation of the effects of patient education on asthma morbidity in general practice. Lancet. 1986;1:26-29.
14. Gibson PG, Coughlan J, Wilson AJ, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev. 2000;2:CD001117.
15. Clark NM, Partridge MR. Strengthening asthma education to enhance disease control. Chest. 2002;121:1661-1669.
16. Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes. Arch Intern Med. 1993;153:1863-1868.
17. Clark NM, Gong M, Schork MA, et al. Long-term effects of asthma education for physicians on patient satisfaction and use of health services. Eur Respir J. 2000;16:15-21.
18. Confino-Cohen R, Melamed S, Goldberg A. Debilitating beliefs, emotional distress and quality of life in patients given immunotherapy for insect sting allergy. Clin Exp Allergy. 1999; 29:1626-1631.